Harold Goldmeier is a financial journalist who writes for Seeking Alpha, Israel National News, and the Jerusalem Post. His articles focus on providing investment insights and analysis, covering a range of industries and companies. Harold's expertise lies in evaluating stocks and identifying potential investment opportunities for readers.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Not enough data
Harold Goldmeier's articles primarily focus on investment analysis, often citing data to support his insights. He concentrates on finance-related topics such as investing in specific stocks and sectors.
Given the nature of his coverage, Harold is likely to be interested in pitches from experts who can provide unique insights into investment opportunities, particularly those related to small-cap stocks or niche sectors within the finance industry. Pitches that offer a fresh perspective on analyzing stock performance or industry trends with supporting data might resonate well with him.
As Harold does not have a specified geographic focus, he appears open to covering global markets and companies. Therefore, sources offering diverse international perspectives in the finance sector could capture his interest.
This information evolves through artificial intelligence and human feedback. Improve this profile .
Oct. 09, 2024 3:58 AM ET Ryanair Holdings plc (RYAAY) Stock Harold Goldmeier 3.56K Follower s Follow
American Water Works is a moderately profitable utility, with growth driven by acquisitions. Find out why we assess AWK stock as a worthwhile hold at this time.
This is also a workbook. Be prepared to put in effort to build and repeatedly rebuild self-confidence and self-esteem. “Each chapter in this book tells the story of one inspirational Jewish woman (among dozens) and then suggests four different ways in which you can mark your bat mitzvah in her honor and make your own contribution to the world around you.”
Microchip Technology Inc. rates as a hold due to weak valuation and momentum metrics despite positive industry trends and analysts' buy ratings. Learn more on MCHP stock here.
Despite current financial struggles, including increased losses, MediWound's revenue is expected to grow. See why I rate MDWD stock as a buy.
From the blog of Harold Goldmeier at The Times of Israel
ResMed Inc. is downgraded from buy to watchful hold due to valuation concerns, despite strong financial performance and growth potential. Explore more details here.
Harold Goldmeier teaches international university students at Touro College Jerusalem.
FMC's strong Q3 '24 performance underscores management's effectiveness in cost containment and debt reduction strategies. See why I rate FMC stock a buy.
By: Harold Goldmeier
(833) 317-6278 
